Correlation Between Maravai Lifesciences and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Maravai Lifesciences and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maravai Lifesciences and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maravai Lifesciences Holdings and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Maravai Lifesciences and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maravai Lifesciences with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maravai Lifesciences and Sonnet Biotherapeutics.
Diversification Opportunities for Maravai Lifesciences and Sonnet Biotherapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Maravai and Sonnet is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Maravai Lifesciences Holdings and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Maravai Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maravai Lifesciences Holdings are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Maravai Lifesciences i.e., Maravai Lifesciences and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Maravai Lifesciences and Sonnet Biotherapeutics
Given the investment horizon of 90 days Maravai Lifesciences Holdings is expected to generate 2.13 times more return on investment than Sonnet Biotherapeutics. However, Maravai Lifesciences is 2.13 times more volatile than Sonnet Biotherapeutics Holdings. It trades about -0.1 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.58 per unit of risk. If you would invest 721.00 in Maravai Lifesciences Holdings on August 27, 2024 and sell it today you would lose (192.00) from holding Maravai Lifesciences Holdings or give up 26.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Maravai Lifesciences Holdings vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Maravai Lifesciences |
| Sonnet Biotherapeutics |
Maravai Lifesciences and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Maravai Lifesciences and Sonnet Biotherapeutics
The main advantage of trading using opposite Maravai Lifesciences and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maravai Lifesciences position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |